Next Article in Journal
Estimation of Gravity Gradients Using Deep Learning for Efficient Positioning with a Quantum Sensor
Previous Article in Journal
Optimization of Ultrasound-Assisted Solvothermal Synthesis of N-Doped Carbon Dots Derived from Water Hyacinth (Pontederia crassipes) for Carbon Monoxide Sensing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Synthesis, Spectral Characteristics, and Molecular Structure of N-(2,2,2-Trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)carboxamides †

by
Yelyzaveta R. Lomynoha
,
Pavlo V. Zadorozhnii
*,
Pavlo V. Romanenko
,
Vadym V. Kiselev
,
Oxana V. Okhtina
and
Aleksandr V. Kharchenko
Department of Pharmacy, Chemistry and Technologies, Ukrainian State University of Science and Technologies, Lazariana St., 2, 49010 Dnipro, Ukraine
*
Author to whom correspondence should be addressed.
Presented at the 6th International Electronic Conference on Applied Sciences, 9–11 December 2025; Available online: https://sciforum.net/event/ASEC2025.
Eng. Proc. 2026, 124(1), 45; https://doi.org/10.3390/engproc2026124045
Published: 24 February 2026
(This article belongs to the Proceedings of The 6th International Electronic Conference on Applied Sciences)

Abstract

1,3-Thiazole derivatives are of interest in pharmacy, medicine, and agriculture as potential biologically active substances. We have proposed for the first time a convenient and effective method for the synthesis of amidoalkylated derivatives of 2-amino-1,3-thiazole. This approach is based on the reaction of amidoalkylated thioureas with α-halocarbonyl compounds. The reaction was carried out under stirring at 20 °C in ethanol with the addition of an equimolar amount of triethylamine to bind the released hydrogen halide. The yield of the obtained 1,3-thiazole derivatives was 68–75%. An attempt to carry out a counter-synthesis by amidoalkylation of the corresponding 2-amino-1,3-thiazole derivative was unsuccessful due to strong resinification of the reaction mass. The structure of the compounds obtained was confirmed by 1H and 13C NMR spectroscopy. The structure was finally confirmed by X-ray structural analysis performed for N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)acetamide.

1. Introduction

Heterocyclic compounds occupy a leading position in modern organic and medicinal chemistry due to their structural diversity and wide spectrum of biological activity. Among them, 1,3-thiazoles are of particular interest, which combine Sulfur and Nitrogen atoms in their structure [1]. This determines their unique electronic and physicochemical properties. The presence of a reactive 1,3-thiazole nucleus makes these compounds convenient platforms for synthetic modification and creation of new biologically active substances [1,2,3,4].
Many 1,3-thiazole derivatives exhibit various pharmacological properties, including anti-inflammatory [5,6,7], antimicrobial [8,9,10], antitumor [4], antifungal [11,12,13], and anticonvulsant [14,15]. Some of them have already become the basis of medicines used in clinical practice, while others are actively studied as promising pharmacophores. In addition, 1,3-thiazoles have found application in agriculture as fungicides, insecticides, and plant growth regulators [16], as well as in materials science as components of new functional materials. Despite significant progress in the chemistry of 1,3-thiazole, further research into new derivatives with specific properties is an urgent task. A promising direction in the creation of new biologically active substances is the combination of the thiazole ring with other pharmacophoric groups. In this study, we report the synthesis of amidoalkylated 1,3-thiazole derivatives. The alkylamide moiety is a well-known pharmacophore [17,18,19,20,21,22,23], and its combination with the 1,3-thiazole ring opens up prospects for the creation of compounds with potential pharmacological and pesticidal activity.

2. Materials and Methods

1H NMR (400 MHz) and 13C NMR (100 MHz) spectra were measured for DMSO-d6 (Sigma-Aldrich, St. Louis, MO, USA) solutions on a Varian Agilent VNMRS 400 MHz spectrometer (Agilent Technologies, Inc., Santa Clara, CA, USA). Residual solvent signals were used as a standard. Elemental analysis was performed on a LECO CHNS-900 instrument (LECO Corporation, St. Joseph, MI, USA). The course of the reaction and the purity of the synthesized compounds were checked by TLC on Silufol UV-254 plates (Serva-Feinbiochemica GmbH & Co, Heidelberg, Germany), using a mixture of chloroform (Allhim, Kyiv, Ukraine) and acetone (WARCHEM, Warsaw, Poland) (3:1) as the eluent. Melting points were determined in open capillaries and were not corrected.
Synthesis of N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)carboxamides (3). A mixture of equimolar amounts (10 mmol) of monoamidoalkylated thiourea 1 [24,25], α-bromoacetophenone 2 (1.99 g) (Sigma-Aldrich, St. Louis, MO, USA), and triethylamine (1.4 mL) (Chimlaborreaktiv LLC, Brovary, Ukraine) in 40 mL of ethanol was stirred at room temperature for 3 h. During the reaction, the precipitate of thiourea 1 disappeared. The resulting solution was filtered, and the filtrate was evaporated at 20 °C and atmospheric pressure. After 24 h, the crystalline product was collected and purified by recrystallization from an appropriate solvent.
N-(2,2,2-Trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)acetamide (3a). Pale yellow crystals; yield 75%. mp 198–200 °C (EtOH). Rf = 0.49. 1H NMR (DMSO-d6), δ: 8.80 d (J = 7.3 Hz, 1H, NH), 8.51 d (J = 8.8 Hz, 1H, NH), 7.84 d (J = 7.3 Hz, 2H, Harom.), 7.40–7.37 m (2H, Harom.), 7.29–7.26 m (1H, Harom.), 7.19 s (1H, CHthiazole), 6.84 dd (J = 8.8, 7.3 Hz, 1H, CH), 1.96 s (3H, CH3). 13C NMR (DMSO-d6), δ: 169.4 (C=O), 165.8 (C=N), 149.4 (C=Cthiazole), 134.5, 128.4, 127.3, 125.6 (Carom.), 103.0 (C=Cthiazole), 101.5 (CCl3), 69.8 (CH), 22.5 (CH3). Anal. Calcd (%) for C13H12Cl3N3OS (364.67): C 42.82; H 3.32; N 11.52; S 8.79. Found: C 42.74; H 3.27; N 11.61; S 8.84.
The crystals of compound 3a are monoclinic, C13H12N3OCl3S, at −100.5 °C: a = 21.0525(5), b = 8.3440(2), c = 9.3233(2) Å, β = 94.339(2)°, V = 1633.06(7) Å3, Mr = 364.67, Z = 4, space group P21/c, dcalc = 1.483 g cm−3, μ(MoKα) = 0.689 mm−1, F(000) = 744. The unit cell parameters and intensities of 18,926 reflections (2860 independent, Rint = 0.028) were measured on a Bruker APEX-II CCD diffractometer (Bruker Corporation, Billerica, MA, USA) (MoKα radiation, CCD detector, graphite monochromator, ω-scan mode, 2θmax = 50°). The structure was solved by direct methods using the OLEX2 program (version 1.5, Olexsys Ltd, Durham University, United Kingdom) [26] with the SHELXT (version 2014/5, Georg-August Universität Göttingen, Göttingen, Germany) [27] and SHELXL (version 2016/6, Georg-August Universität Göttingen, Göttingen, Germany) [28] software packages. The positions of hydrogen atoms were located from difference Fourier maps and refined using a riding model with Uiso = nUeq of the carrier atom (n = 1.5 for methyl groups and n = 1.2 for other hydrogen atoms). Hydrogen atoms of the amino groups were refined isotropically. The structure was refined against F2 by full-matrix least-squares in anisotropic approximation for all non-hydrogen atoms to wR2 = 0.0861 for 2860 reflections (R1 = 0.0332 for 2467 reflections with F > 4σ(F), S = 1.044). The final atomic coordinates, and crystallographic data for compound 3a have been deposited to with the Cambridge Crystallographic Data Centre, 12 Union Road, CB2 1EZ, UK (fax: +44–1223-336,033; e-mail: deposit@ccdc.cam.ac.uk) and are available on request quoting the deposition numbers CCDC 2489840).
N-(2,2,2-Trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)cinnamamide (3b). Pale yellow crystals; yield 68%. mp 214–216 °C (MeCN). Rf = 0.69. 1H NMR (DMSO-d6), δ: 8.99 d (J = 8.8 Hz, 1H, NH), 8.65 d (J = 8.8 Hz, 1H, NH), 7.85 d (J = 7.3 Hz, 2H, Harom.), 7.59–7.55 m (3H, Harom. + C6H5CH=CH), 7.42–7.37 m (5H, Harom.), 7.29–7.26 m (1H, Harom.), 7.21 s (1H, CHthiazole), 7.00–6.91 m (2H, CH + C6H5CH=CH). 13C NMR (DMSO-d6), δ: 165.7 (C=O), 164.8 (C=N), 149.4 (C=Cthiazole), 140.8 (C6H5CH=CH), 134.6, 134.5, 129.7, 128.8, 128.3, 127.6, 127.3, 125.7 (Carom.), 121.0 (C6H5CH=CH), 103.1 (C=Cthiazole), 101.4 (CCl3), 71.0 (CH). Anal. Calcd (%) for C20H16Cl3N3OS (452.78): C 53.05; H 3.56; N 9.28; S 7.08. Found: C 53.12; H 3.49; N 9.37; S 7.14.
N-(2,2,2-Trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)benzamide (3c). Pale yellow crystals; yield 70%. mp 197–199 °C (MeCN). Rf = 0.84. 1H NMR (DMSO-d6), δ: 9.25 d (J = 8.3 Hz, 1H, NH), 8.39 d (J = 8.8 Hz, 1H, NH), 7.90–7.85 m (4H, Harom.), 7.59–7.55 m (1H, Harom.), 7.51–7.47 m (2H, Harom.), 7.41–7.37 m (2H, Harom.), 7.29–7.26 m (1H, Harom.), 7.24 s (1H, CHthiazole), 7.03 dd (J = 8.8, 8.3 Hz, 1H, CH). 13C NMR (DMSO-d6), δ: 166.6 (C=O), 165.7 (C=N), 149.3 (C=Cthiazole), 134.4, 133.4, 131.9, 128.5, 128.3, 127.7, 127.5, 125.6 (Carom.), 103.6 (C=Cthiazole), 101.5 (CCl3), 70.8 (CH). Anal. Calcd (%) for C18H14Cl3N3OS (426.74): C 50.66; H 3.31; N 9.85; S 7.51. Found: C 50.58; H 3.27; N 9.92; S 7.60.

3. Results and Discussion

The starting N-(2,2,2-trichloro-1-thioureidoethyl)carboxamides 1 were prepared previously [24,25]. These compounds readily reacted with α-bromoacetophenone 2 to give the corresponding N-amidoalkylated 1,3-thiazole derivatives 3 (Scheme 1). The reaction was carried out under stirring at 20 °C in ethanol with the addition of an equimolar amount of triethylamine to neutralize HBr. N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)carboxamides 3 were obtained in 68–75% yield. Attempts to perform the countersynthesis of compounds 3 by amidoalkylation of 4-phenylthiazol-2-amine 6 were unsuccessful. In this case, strong tarring of the reaction mixture was observed, and the product could not be isolated.
The structures of compounds 3 and 5 were confirmed by 1H and 13C NMR spectroscopy, as well as by X-ray structural analysis (see Figures S1–S7 and Tables S1–S4 in Supplementary Materials). In the 1H NMR spectra, the characteristic doublet signals of two NH protons appeared in the region of 9.25–8.39 ppm. In addition, the signals of two CH protons were indicative, one of which appeared as a singlet at 7.24–7.19 ppm and belongs to the thiazole ring, and the other appeared as a doublet of doublets at 7.03–6.84 ppm and corresponds to the alkylamide fragment. In the 13C NMR spectra, the signals of carbon atoms C=O, CCl3, and CH of the alkylamide fragment were characteristic, appearing in the region of 169.4–165.7, 101.5–101.4, and 71.0–69.8 ppm, respectively. Also indicative were the signals of the three carbon atoms of the thiazole ring, which appeared in the region of 165.8–164.8 (C=N), 149.4–149.3 and 103.6–103.0 (C=C) ppm.
For compound 3a, an X-ray structural study was performed (Figure 1). The phenyl substituent at atom C1 is slightly non-coplanar with the thiazole ring plane (torsion angle C2–C1–C8–C13 -13.7(4)°) due to steric repulsion between the two rings (shortened intramolecular contacts H9…N1 2.51 Å and H13…C2 2.75 Å compared to the sums of van der Waals radii [29] of 2.68 Å and 2.84 Å, respectively). The amino group at the C3 substituent of the thiazole ring adopts a pyramidal configuration, with the sum of the valence angles centered on the nitrogen atom amounting to 346°. Atom C4 of the substituent is located in a nearly syn-periplanar orientation relative to the endocyclic N1–C3 bond, whereas the trichloromethyl group adopts an –ac conformation relative to the exocyclic C3–N2 bond (torsion angles N1–C3–N2–C4 18.0(3)°, C3–N2–C4–C5 −145.4(2)°). The methylcarbamoyl fragment is oriented orthogonally to the C3–N2 bond (torsion angle C3–N2–C4–N3 89.4(2)°) and is significantly rotated with respect to the N2–C4 bond (torsion angle N2–C4–N3–C6 −126.4(2)°). Conjugation between the π-orbital of the C6=O1 carbonyl group and the lone pair of electrons on atom N3 results in a planar configuration of the N3H amino group (sum of valence angles centered on the nitrogen atom is 359°).
In the crystal, molecules of 3a form chains (Figure 2) along the crystallographic [001] direction, which are linked by intermolecular hydrogen bonds N2–H…O1’ (symmetry operation x, 1.5-y, 0.5+z; H2…O1 distance 2.22(2) Å, N2–H…O1 angle 144(2)°) and N3–H…O1’ (symmetry operation x, 1.5-y, 0.5+z; H3…O1 distance 2.15(3) Å, N3–H…O1 angle 148(2)°). The oxygen atom acts as a bifurcated proton acceptor in these hydrogen bonds.

4. Conclusions

We have developed a preparative method for the first time to synthesize N-amidoalkylated derivatives of 1,3-thiazole. The structure of the synthesized compounds has been reliably confirmed by 1H and 13C NMR spectroscopy and X-ray structural analysis. The obtained compounds are of interest as potential biologically active substances.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/engproc2026124045/s1, Figure S1: 1H NMR (400 MHz, DMSO-d6) spectra of N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)acetamide (3a); Figure S2: 13C NMR (100 MHz, DMSO-d6 + CDCl3) spectra of N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)acetamide (3a); Figure S3: 1H NMR (400 MHz, DMSO-d6) spectra of N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)cinnamamide (3b); Figure S4: 13C NMR (100 MHz, DMSO-d6) spectra of N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)cinnamamide (3b); Figure S5: 1H NMR (400 MHz, DMSO-d6) spectra of N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)benzamide (3c); Figure S6: 13C NMR (100 MHz, DMSO-d6) spectra of N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)benzamide (3c); Figure S7: Molecular structure of compound 3a according to XRD. Atoms are shown as 50 thermal ellipsoids; Table S1: Atomic coordinates (×104) and isotropic thermal parameters (Å2 × 103) of atoms in N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)acetamide (3a); Table S2: Bond lengths (Å) in N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)acetamide (3a); Table S3: Angles (º) in N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)acetamide (3a); Table S4: Torsion angles (º) in N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)acetamide (3a).

Author Contributions

Conceptualization, P.V.Z.; methodology, P.V.Z., Y.R.L., O.V.O. and P.V.R.; validation, V.V.K. and A.V.K.; formal analysis, Y.R.L., P.V.Z., P.V.R. and O.V.O.; investigation: Y.R.L., P.V.Z. and P.V.R.; resources, V.V.K.; writing—original draft preparation, P.V.Z.; writing—review and editing, V.V.K. and A.V.K.; visualization, P.V.Z.; supervision, A.V.K.; project administration, P.V.Z.; funding acquisition, P.V.Z. All authors have read and agreed to the published version of the manuscript.

Funding

The research was funded by the Ministry of Education and Science of Ukraine, the project “New principles of synthesis of fluorescent materials and biologically active N,S-containing heterocycles” (state registration number 0123U101168).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Fernandes, S.T.; Damodara, J.; DSouza, S.M. Evaluation of 1,3-Thiazole Derivatives with Pharmaceutical and Chemical Activity: A Review. Heterocycles 2023, 106, 819. [Google Scholar] [CrossRef]
  2. Kumari, G.; Dhillon, S.; Rani, P.; Chahal, M.; Aneja, D.K.; Kinger, M. Development in the Synthesis of Bioactive Thiazole-Based Heterocyclic Hybrids Utilizing Phenacyl Bromide. ACS Omega 2024, 9, 18709–18746. [Google Scholar] [CrossRef] [PubMed]
  3. Souza Tada da Cunha, P.; Rodriguez Gini, A.L.; Man Chin, C.; dos Santos, J.L.; Benito Scarim, C. Recent Progress in Thiazole, Thiosemicarbazone, and Semicarbazone Derivatives as Antiparasitic Agents Against Trypanosomatids and Plasmodium spp. Molecules 2025, 30, 1788. [Google Scholar] [CrossRef]
  4. Rana, R.; Kumar, N.; Gulati, H.K.; Sharma, A.; Khanna, A.; Pooja; Badhwar, R.; Dhir, M.; Jyoti; Vir Singh, J.; et al. A comprehensive review on thiazole based conjugates as anti-cancer agents. J. Mol. Struct. 2023, 1292, 136194. [Google Scholar] [CrossRef]
  5. Narasimhamurthy, K.H.; Swaroop, T.R.; Rangappa, K.S. A review on progress of thiazole derivatives as potential anti-inflammatory agents. Eur. J. Med. Chem. Rep. 2024, 12, 100225. [Google Scholar] [CrossRef]
  6. Sharma, R.N.; Xavier, F.P.; Vasu, K.K.; Chaturvedi, S.C.; Pancholi, S.S. Synthesis of 4-benzyl-1,3-thiazole derivatives as potential anti-inflammatory agents: An analogue-based drug design approach. J. Enzym. Inhib. Med. Chem. 2009, 24, 890–897. [Google Scholar] [CrossRef]
  7. Liaras, K.; Fesatidou, M.; Geronikaki, A. Thiazoles and Thiazolidinones as COX/LOX Inhibitors. Molecules 2018, 23, 685. [Google Scholar] [CrossRef]
  8. Khamitova, A.; Berillo, D.; Lozynskyi, A.; Konechnyi, Y.; Mural, D.; Georgiyants, V.; Lesyk, R. Thiadiazole and Thiazole Derivatives as Potential Antimicrobial Agents. Mini Rev. Med. Chem. 2024, 24, 531–545. [Google Scholar] [CrossRef]
  9. Mohanty, P.; Behera, S.; Behura, R.; Shubhadarshinee, L.; Mohapatra, P.; Barick, A.K.; Jali, B.R. Antibacterial Activity of Thiazole and its Derivatives: A Review. Biointerface Res. Appl. Chem. 2022, 12, 2171–2195. [Google Scholar] [CrossRef]
  10. Saffour, S.; AL-Sharabi, A.A.; Evren, A.E.; Cankiliç, M.Y.; Yurttaş, L. Antimicrobial activity of novel substituted 1,2,4-triazole and 1,3-thiazole derivatives. J. Mol. Struct. 2024, 1295, 136675. [Google Scholar] [CrossRef]
  11. Pricopie, A.-I.; Ionuț, I.; Marc, G.; Arseniu, A.-M.; Vlase, L.; Grozav, A.; Găină, L.I.; Vodnar, D.C.; Pîrnău, A.; Tiperciuc, B.; et al. Design and Synthesis of Novel 1,3-Thiazole and 2-Hydrazinyl-1,3-Thiazole Derivatives as Anti-Candida Agents: In Vitro Antifungal Screening, Molecular Docking Study, and Spectroscopic Investigation of their Binding Interaction with Bovine Serum Albumin. Molecules 2019, 24, 3435. [Google Scholar] [CrossRef]
  12. Biernasiuk, A.; Berecka-Rycerz, A.; Gumieniczek, A.; Malm, M.; Łączkowski, K.Z.; Szymańska, J.; Malm, A. The newly synthesized thiazole derivatives as potential antifungal compounds against Candida albicans. Appl. Microbiol. Biotechnol. 2021, 105, 6355–6367. [Google Scholar] [CrossRef]
  13. Singh, U.P.; Bhat, H.R.; Gahtori, P. Antifungal activity, SAR and physicochemical correlation of some thiazole-1,3,5-triazine derivatives. J. Mycol. Med. 2012, 22, 134–141. [Google Scholar] [CrossRef]
  14. Yamsani, N.; Sundararajan, R. Design, In-Silico Studies, Synthesis, Characterization, and Anticonvulsant Activities of Novel Thiazolidin-4-One Substituted Thiazole Derivatives. Biointerface Res. Appl. Chem. 2023, 13, 366. [Google Scholar] [CrossRef]
  15. Mishchenko, M.; Shtrygol, S.; Kaminskyy, D.; Lesyk, R. Thiazole-Bearing 4-Thiazolidinones as New Anticonvulsant Agents. Sci. Pharm. 2020, 88, 16. [Google Scholar] [CrossRef]
  16. Wang, J.; Liao, A.; Guo, R.J.; Ma, X.; Wu, J. Thiazole and Isothiazole Chemistry in Crop Protection. J. Agric. Food Chem. 2025, 73, 30–46. [Google Scholar] [CrossRef] [PubMed]
  17. Boyce, M.; Bryant, K.F.; Jousse, C.; Long, K.; Harding, H.P.; Scheuner, D.; Kaufman, R.J.; Ma, D.; Coen, D.M.; Ron, D.; et al. A Selective Inhibitor of eIF2α Dephosphorylation Protects Cells from ER Stress. Science 2005, 307, 935–939. [Google Scholar] [CrossRef]
  18. Long, K.; Boyce, M.; Lin, H.; Yuan, J.; Ma, D. Structure-activity relationship studies of salubrinal lead to its active biotinylated derivative. Bioorg. Med. Chem. Lett. 2005, 15, 3849–3852. [Google Scholar] [CrossRef] [PubMed]
  19. Zadorozhnii, P.V.; Pokotylo, I.O.; Kiselev, V.V.; Okhtina, O.V.; Kharchenko, A.V. Molecular docking studies of salubrinal and its analogs as inhibitors of the GADD34:PP1 enzyme. ADMET DMPK 2019, 7, 140–150. [Google Scholar] [CrossRef] [PubMed]
  20. Liu, J.; He, K.L.; Li, X.; Li, R.J.; Liu, C.L.; Zhong, W.; Li, S. SAR, Cardiac Myocytes Protection Activity and 3D-QSAR Studies of Salubrinal and its Potent Derivatives. Curr. Med. Chem. 2012, 19, 6072–6079. [Google Scholar] [CrossRef]
  21. Zadorozhnii, P.V.; Kiselev, V.V.; Kharchenko, A.V. In Silico ADME Profiling of Salubrinal and Its Analogues. Future Pharmacol. 2022, 2, 160–197. [Google Scholar] [CrossRef]
  22. Zadorozhnii, P.V.; Kiselev, V.V.; Kharchenko, A.V. In Silico toxicity evaluation of Salubrinal and its analogues. Eur. J. Pharm. Sci. 2020, 155, 105538. [Google Scholar] [CrossRef]
  23. Chen, Y.; Li, B.; Xu, Y.; Zhou, T.; Zhao, C.; Zhao, J. Sal003 alleviated intervertebral disc degeneration by inhibiting apoptosis and extracellular matrix degradation through suppressing endoplasmic reticulum stress pathway in rats. Front. Pharmacol. 2023, 14, 1095307. [Google Scholar] [CrossRef] [PubMed]
  24. Lomynoha, Y.R.; Zadorozhnii, P.V.; Kiselev, V.V.; Kharchenko, A.V. Synthesis, spectral characteristics and molecular docking studies of N-(2,2,2-trichloro-1-thioureidoethyl)carboxamides. Acta Chem. Iasi 2025, 33, 25–42. [Google Scholar] [CrossRef]
  25. Pokotylo, I.O.; Zadorozhnii, P.V.; Kiselev, V.V.; Lominoga, E.A. Synthesis and Spectral Characteristics of N-(2,2,2-Trichloro-1-Thioureidoethyl) Carboxamides and 2-(1-Carboxamido-2,2,2-Trichloroethyl) Isothiouronium Chlorides. Biointerface Res. Appl. Chem. 2024, 14, 17. [Google Scholar] [CrossRef]
  26. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  27. Sheldrick, G.M. SHELXT—Integrated space-group and crystal-structure determination. Acta Crystallogr. Sect. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  28. Sheldrick, G.M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. Sect. C Cryst. Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  29. Hu, S.Z.; Zhou, Z.H.; Xie, Z.X.; Robertson, B.E. A comparative study of crystallographic van der Waals radii. Z. Kristallogr. Cryst. Mater. 2014, 229, 517–523. [Google Scholar] [CrossRef]
Scheme 1. Synthesis of N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)carboxamides (3ac).
Scheme 1. Synthesis of N-(2,2,2-trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)carboxamides (3ac).
Engproc 124 00045 sch001
Figure 1. Molecular structure of compound 3a according to XRD. Atoms are shown as 50% thermal ellipsoids.
Figure 1. Molecular structure of compound 3a according to XRD. Atoms are shown as 50% thermal ellipsoids.
Engproc 124 00045 g001
Figure 2. Chains of molecules 3a along the crystallographic [001] direction. Hydrogen bonds are shown as blue lines.
Figure 2. Chains of molecules 3a along the crystallographic [001] direction. Hydrogen bonds are shown as blue lines.
Engproc 124 00045 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lomynoha, Y.R.; Zadorozhnii, P.V.; Romanenko, P.V.; Kiselev, V.V.; Okhtina, O.V.; Kharchenko, A.V. Synthesis, Spectral Characteristics, and Molecular Structure of N-(2,2,2-Trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)carboxamides. Eng. Proc. 2026, 124, 45. https://doi.org/10.3390/engproc2026124045

AMA Style

Lomynoha YR, Zadorozhnii PV, Romanenko PV, Kiselev VV, Okhtina OV, Kharchenko AV. Synthesis, Spectral Characteristics, and Molecular Structure of N-(2,2,2-Trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)carboxamides. Engineering Proceedings. 2026; 124(1):45. https://doi.org/10.3390/engproc2026124045

Chicago/Turabian Style

Lomynoha, Yelyzaveta R., Pavlo V. Zadorozhnii, Pavlo V. Romanenko, Vadym V. Kiselev, Oxana V. Okhtina, and Aleksandr V. Kharchenko. 2026. "Synthesis, Spectral Characteristics, and Molecular Structure of N-(2,2,2-Trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)carboxamides" Engineering Proceedings 124, no. 1: 45. https://doi.org/10.3390/engproc2026124045

APA Style

Lomynoha, Y. R., Zadorozhnii, P. V., Romanenko, P. V., Kiselev, V. V., Okhtina, O. V., & Kharchenko, A. V. (2026). Synthesis, Spectral Characteristics, and Molecular Structure of N-(2,2,2-Trichloro-1-((4-phenylthiazol-2-yl)amino)ethyl)carboxamides. Engineering Proceedings, 124(1), 45. https://doi.org/10.3390/engproc2026124045

Article Metrics

Back to TopTop